A proteome-wide atlas of drug mechanism of action

[1]  Edward L. Huttlin,et al.  Proteome-wide mapping of short-lived proteins in human cells. , 2021, Molecular cell.

[2]  S. Gygi,et al.  A Semiautomated Paramagnetic Bead-Based Platform for Isobaric Tag Sample Preparation. , 2021, Journal of the American Society for Mass Spectrometry.

[3]  Devin K. Schweppe,et al.  Reimagining high-throughput profiling of reactive cysteines for cell-based screening of large electrophile libraries , 2021, Nature Biotechnology.

[4]  Ramin Rad,et al.  Dual proteome-scale networks reveal cell-specific remodeling of the human interactome , 2020, Cell.

[5]  Ramin Rad,et al.  Improved Monoisotopic Mass Estimation for Deeper Proteome Coverage. , 2020, Journal of proteome research.

[6]  Ursula Klingmüller,et al.  mTOR-mediated cancer drug resistance suppresses autophagy and generates a druggable metabolic vulnerability , 2020, Nature Communications.

[7]  Andy Liaw,et al.  A mass spectrometry-based proteome map of drug action in lung cancer cell lines , 2020, Nature Chemical Biology.

[8]  Christoph B. Messner,et al.  Ultra-High-Throughput Clinical Proteomics Reveals Classifiers of COVID-19 Infection , 2020, Cell Systems.

[9]  Edward L. Huttlin,et al.  Selection of Heating Temperatures Improves the Sensitivity of Proteome Integral Solubility Alteration (PISA) Assay. , 2020, Journal of proteome research.

[10]  Devin K. Schweppe,et al.  TMTpro reagents: a set of isobaric labeling mass tags enables simultaneous proteome-wide measurements across 16 samples , 2020, Nature Methods.

[11]  M. Mckee,et al.  Estimated Research and Development Investment Needed to Bring a New Medicine to Market, 2009-2018. , 2020, JAMA.

[12]  Florian P Bayer,et al.  Robust, reproducible and quantitative analysis of thousands of proteomes by micro-flow LC–MS/MS , 2020, Nature Communications.

[13]  E. Robert McDonald,et al.  Quantitative Proteomics of the Cancer Cell Line Encyclopedia , 2020, Cell.

[14]  Agnieszka Wróbel,et al.  Trimethoprim and other nonclassical antifolates an excellent template for searching modifications of dihydrofolate reductase enzyme inhibitors , 2019, The Journal of Antibiotics.

[15]  R. Zubarev,et al.  Proteome Integral Solubility Alteration (PISA): a high-throughput proteomics assay for target deconvolution. , 2019, Journal of proteome research.

[16]  A. Lin,et al.  Off-target toxicity is a common mechanism of action of cancer drugs undergoing clinical trials , 2019, Science Translational Medicine.

[17]  Sarah A. Boswell,et al.  Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity. , 2019, Cell chemical biology.

[18]  Ramin Rad,et al.  Full-featured, real-time database searching platform enables fast and accurate multiplexed quantitative proteomics , 2019, bioRxiv.

[19]  T. Natsume,et al.  Intrinsically Disordered Protein TEX264 Mediates ER-phagy. , 2019, Molecular cell.

[20]  Vladimir Denic,et al.  TEX264 Is an Endoplasmic Reticulum-Resident ATG8-Interacting Protein Critical for ER Remodeling during Nutrient Stress. , 2019, Molecular cell.

[21]  Susan E. Abbatiello,et al.  Characterization and Optimization of Multiplexed Quantitative Analyses Using High-Field Asymmetric-Waveform Ion Mobility Mass Spectrometry. , 2019, Analytical chemistry.

[22]  Julian Mintseris,et al.  Active Instrument Engagement Combined with a Real-Time Database Search for Improved Performance of Sample Multiplexing Workflows. , 2019, Journal of proteome research.

[23]  Roman A. Zubarev,et al.  ProTargetMiner as a proteome signature library of anticancer molecules for functional discovery , 2019, Nature Communications.

[24]  Christopher S. Hughes,et al.  Single-pot, solid-phase-enhanced sample preparation for proteomics experiments , 2018, Nature Protocols.

[25]  Benjamin L Ebert,et al.  Defining the human C2H2 zinc finger degrome targeted by thalidomide analogs through CRBN , 2018, Science.

[26]  Jianmin Wang,et al.  Mechanism of FACT removal from transcribed genes by anticancer drugs curaxins , 2018, Science Advances.

[27]  Lijuan Bu,et al.  Procaspase-3-activating compound 1 stabilizes hypoxia-inducible factor 1α and induces DNA damage by sequestering ferrous iron , 2018, Cell Death & Disease.

[28]  A. D. Falco,et al.  Aroylhydrazones constitute a promising class of ‘metal-protein attenuating compounds’ for the treatment of Alzheimer’s disease: a proof-of-concept based on the study of the interactions between zinc(II) and pyridine-2-carboxaldehyde isonicotinoyl hydrazone , 2018, JBIC Journal of Biological Inorganic Chemistry.

[29]  Wei Zhang,et al.  Structure-Guided Design and Development of Potent and Selective Dual Bromodomain 4 (BRD4)/Polo-like Kinase 1 (PLK1) Inhibitors. , 2018, Journal of medicinal chemistry.

[30]  C. Foulds.  Disrupting a negative feedback loop drives endocrine therapy-resistant breast cancer , 2018, Proceedings of the National Academy of Sciences.

[31]  Steven P Gygi,et al.  Streamlined Tandem Mass Tag (SL-TMT) Protocol: An Efficient Strategy for Quantitative (Phospho)proteome Profiling Using Tandem Mass Tag-Synchronous Precursor Selection-MS3. , 2018, Journal of proteome research.

[32]  Michael J. MacCoss,et al.  A Library of Phosphoproteomic and Chromatin Signatures for Characterizing Cellular Responses to Drug Perturbations , 2017, bioRxiv.

[33]  Angela N. Brooks,et al.  A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles , 2017, Cell.

[34]  Tobias Karlberg,et al.  Structural Basis for Potency and Promiscuity in Poly(ADP-ribose) Polymerase (PARP) and Tankyrase Inhibitors. , 2017, Journal of medicinal chemistry.

[35]  E. Deeks.  Ibrutinib: A Review in Chronic Lymphocytic Leukaemia , 2017, Drugs.

[36]  N. Hannett,et al.  Covalent targeting of remote cysteine residues to develop CDK12 and CDK13 inhibitors. , 2016, Nature chemical biology.

[37]  Marco Y. Hein,et al.  The Perseus computational platform for comprehensive analysis of (prote)omics data , 2016, Nature Methods.

[38]  R. Aebersold,et al.  On the Dependency of Cellular Protein Levels on mRNA Abundance , 2016, Cell.

[39]  Minoru Kanehisa,et al.  KEGG as a reference resource for gene and protein annotation , 2015, Nucleic Acids Res..

[40]  M. Schroeder,et al.  Drug target prioritization by perturbed gene expression and network information , 2015, Scientific Reports.

[41]  Junjie Chen,et al.  Tankyrase Inhibitors Target YAP by Stabilizing Angiomotin Family Proteins. , 2015, Cell reports.

[42]  T. P. Neufeld,et al.  Bafilomycin A1 disrupts autophagic flux by inhibiting both V-ATPase-dependent acidification and Ca-P60A/SERCA-dependent autophagosome-lysosome fusion , 2015, Autophagy.

[43]  Roman A. Zubarev,et al.  Functional Identification of Target by Expression Proteomics (FITExP) reveals protein targets and highlights mechanisms of action of small molecule drugs , 2015, Scientific Reports.

[44]  A. Kuglstatter,et al.  Structure-based drug design of RN486, a potent and selective Bruton's tyrosine kinase (BTK) inhibitor, for the treatment of rheumatoid arthritis. , 2015, Journal of medicinal chemistry.

[45]  Jeroen Krijgsveld,et al.  Ultrasensitive proteome analysis using paramagnetic bead technology , 2014, Molecular systems biology.

[46]  Jeremy L. Jenkins,et al.  Structure of the DDB1-CRBN E3 ubiquitin ligase in complex with thalidomide , 2014, Nature.

[47]  Edward L. Huttlin,et al.  MultiNotch MS3 Enables Accurate, Sensitive, and Multiplexed Detection of Differential Expression across Cancer Cell Line Proteomes , 2014, Analytical chemistry.

[48]  S. Carr,et al.  Lenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells , 2014, Science.

[49]  S. Knapp,et al.  RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain , 2013, Proceedings of the National Academy of Sciences.

[50]  P. Clemons,et al.  Target identification and mechanism of action in chemical biology and drug discovery. , 2013, Nature chemical biology.

[51]  K. Pallauf,et al.  TMEM59 defines a novel ATG16L1‐binding motif that promotes local activation of LC3 , 2013, The EMBO journal.

[52]  J. Eng,et al.  Comet: An open‐source MS/MS sequence database search tool , 2013, Proteomics.

[53]  O. Kepp,et al.  Association and dissociation of autophagy, apoptosis and necrosis by systematic chemical study , 2011, Oncogene.

[54]  S. Gygi,et al.  MS3 eliminates ratio distortion in isobaric labeling-based multiplexed quantitative proteomics , 2011, Nature Methods.

[55]  R. Young,et al.  BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc , 2011, Cell.

[56]  A. Bauer,et al.  RNF146 is a poly(ADP-ribose)-directed E3 ligase that regulates axin degradation and Wnt signalling , 2011, Nature Cell Biology.

[57]  J. Acebes,et al.  Activation of p53 by Nutlin-3a Induces Apoptosis and Cellular Senescence in Human Glioblastoma Multiforme , 2011, PloS one.

[58]  Edward L. Huttlin,et al.  A Tissue-Specific Atlas of Mouse Protein Phosphorylation and Expression , 2010, Cell.

[59]  E. Lundberg,et al.  Towards a knowledge-based Human Protein Atlas , 2010, Nature Biotechnology.

[60]  William B. Smith,et al.  Selective inhibition of BET bromodomains , 2010, Nature.

[61]  Peer Bork,et al.  Drug-Induced Regulation of Target Expression , 2010, PLoS Comput. Biol..

[62]  A. El-Osta,et al.  γH2AX: a sensitive molecular marker of DNA damage and repair , 2010, Leukemia.

[63]  J. Dering,et al.  PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro , 2009, Breast Cancer Research.

[64]  M. Barbacid,et al.  Cell cycle, CDKs and cancer: a changing paradigm , 2009, Nature Reviews Cancer.

[65]  L. Johnson,et al.  The structure of P‐TEFb (CDK9/cyclin T1), its complex with flavopiridol and regulation by phosphorylation , 2008, The EMBO journal.

[66]  Korbinian Strimmer,et al.  fdrtool: a versatile R package for estimating local and tail area-based false discovery rates , 2008, Bioinform..

[67]  Steven P Gygi,et al.  Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry , 2007, Nature Methods.

[68]  M. Tricklebank.  JP‐1302: a new tool to shed light on the roles of α2C‐adrenoceptors in brain , 2007 .

[69]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[70]  Andrew H. Thompson,et al.  Tandem mass tags: a novel quantification strategy for comparative analysis of complex protein mixtures by MS/MS. , 2003, Analytical chemistry.